Easywell Biomedicals, Inc.

Informe acción TPEX:1799

Capitalización de mercado: NT$8.9b

Easywell Biomedicals Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

James Aiping Lee

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO3.4%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Feb 12
What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

CEO

James Aiping Lee

no data

Permanencia

Mr. James Aiping Lee, Ph D, is President of Easywell Biomedicals, Inc and serves as its Manager. He has extensive experience in both medical device and pharmaceutical industries.As the founder of Magnific...